We are live on ! Find out more
Marshall Wace

Marshall Wace Portfolio holdings

AUM $100B
1-Year Est. Return 35.1%
This Fund
S&P 500
This Quarter Est. Return
+8.27%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$21.8B
AUM Growth
+$3.36B
Cap. Flow
+$2.78B
Cap. Flow %
12.74%
Top 10 Hldgs %
12.04%
Holding
3,109
New
1,280
Increased
559
Reduced
519
Closed
699

Sector Composition

Rank Sector Weight
1 Healthcare 20.03%
2 Consumer Discretionary 13.15%
3 Technology 10.68%
4 Financials 9.81%
5 Communication Services 8.69%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BKEP
1951
DELISTED
Blueknight Energy Partners L.P.
BKEP
$482K ﹤0.01%
+148,677
New +$359K
VUG icon
1952
Vanguard Growth ETF
VUG
$216B
$478K ﹤0.01%
+11,160
New +$477K
GRTX
1953
DELISTED
Galera Therapeutics, Inc. Common Stock
GRTX
$478K ﹤0.01%
+54,114
New +$594K
CEQP
1954
DELISTED
Crestwood Equity Partners LP
CEQP
$478K ﹤0.01%
+17,137
New +$386K
IDN icon
1955
Intellicheck
IDN
$73.7M
$477K ﹤0.01%
+56,936
New +$667K
TKC icon
1956
Turkcell
TKC
$4.78B
$477K ﹤0.01%
+102,107
New +$562K
CPRX
1957
DELISTED
Catalyst Pharmaceutical
CPRX
$476K ﹤0.01%
103,332
-38,466
-27% -$153K
BG icon
1958
Bunge Global
BG
$22.8B
$474K ﹤0.01%
5,976
-44,551
-88% -$3.31M
YTEN
1959
DELISTED
Yield10 Bioscience, Inc. Common Stock
YTEN
$474K ﹤0.01%
+1,574
New +$532K
AAOI icon
1960
Applied Optoelectronics
AAOI
$7.07B
$473K ﹤0.01%
+56,578
New +$568K
STSA
1961
DELISTED
Satsuma Pharmaceuticals, Inc. Common Stock
STSA
$472K ﹤0.01%
+79,788
New +$483K
OMAB icon
1962
Grupo Aeroportuario Centro Norte
OMAB
$5.23B
$470K ﹤0.01%
9,297
-11,901
-56% -$598K
GILT icon
1963
Gilat Satellite Networks
GILT
$812M
$469K ﹤0.01%
+44,841
New +$551K
VSTA
1964
DELISTED
Vasta Platform
VSTA
$468K ﹤0.01%
47,515
+35,758
+304% +$476K
AGRO icon
1965
Adecoagro
AGRO
$1.45B
$464K ﹤0.01%
+59,019
New +$476K
BBW icon
1966
Build-A-Bear
BBW
$443M
$464K ﹤0.01%
+67,303
New +$414K
ONDS icon
1967
Ondas Inc
ONDS
$4.48B
$462K ﹤0.01%
+47,643
New +$558K
AEYE icon
1968
AudioEye
AEYE
$75.8M
$461K ﹤0.01%
+16,525
New +$486K
CMCL icon
1969
Caledonia Mining Corp
CMCL
$361M
$461K ﹤0.01%
32,258
-4,940
-13% -$76K
LPLA icon
1970
LPL Financial
LPLA
$27.4B
$458K ﹤0.01%
3,219
-37,140
-92% -$4.74M
HTOO icon
1971
Fusion Fuel Green
HTOO
$8.84M
$457K ﹤0.01%
+974
New +$602K
LMAT icon
1972
LeMaitre Vascular
LMAT
$2.34B
$455K ﹤0.01%
9,326
-37,568
-80% -$1.76M
PSTL
1973
Postal Realty Trust
PSTL
$713M
$454K ﹤0.01%
+26,437
New +$432K
PFG icon
1974
Principal Financial Group
PFG
$24.6B
$451K ﹤0.01%
7,521
-27,724
-79% -$1.55M
BFX
1975
DELISTED
BowFlex Inc.
BFX
$450K ﹤0.01%
28,745
-151,236
-84% -$3.25M

Similar funds

Marshall Wace's Q1 2021 Portfolio in Review

As of Q1 2021, Marshall Wace held 3,109 positions worth $21.8B, up 18% from $18.5B the previous quarter. Its ten largest holdings account for 12% of the portfolio.

Marshall Wace deployed $2.78B of net new capital in Q1 2021, opening 1,280 new positions and adding to 559 existing holdings. Its largest new stake was Paramount Global Class B: 5,936,494 shares worth $268M.

By sector, the portfolio is most concentrated in Healthcare at 20% of assets, down from 28% a quarter earlier, followed by Consumer Discretionary and Technology.

On the sell side, the largest reduction was Thermo Fisher Scientific, an estimated $204M trimmed.

  • Marshall Wace's largest Q1 2021 buy was Paramount Global Class B: 5,936,494 shares worth $268M.
  • Marshall Wace added most to Farfetch Limited Class A Ordinary Shares in Q1 2021, an estimated $182M increase.
  • Marshall Wace's biggest Q1 2021 reduction was Thermo Fisher Scientific, cutting an estimated $204M.
  • Marshall Wace fully exited Vanguard Intermediate-Term Corporate Bond ETF in Q1 2021, selling an estimated $76.2M.
  • Marshall Wace's ten largest holdings make up 12% of its $21.8B portfolio in Q1 2021.
  • Marshall Wace opened 1,280 new positions and closed 699 in Q1 2021.
  • Marshall Wace's portfolio value rose 18% quarter-over-quarter to $21.8B.

Based on Marshall Wace's 13F filing for Q1 2021, filed 17 May 2021.